STOCK TITAN

If You Invested in Gentherm Inc (THRM)

Consumer Cyclical · Auto Parts · NASDAQ
Looking for the current price? See the THRM quote & overview
$1,000 invested 1 Year Ago
$896
-10.4% price return
-4.5% with dividends reinvested
Bought on Nov 19, 2025 at $33.87 split-adjusted
$1,000 invested 5 Years Ago
$355
-64.5% price return -18.7% CAGR
-62.2% with dividends reinvested
Bought on Nov 19, 2021 at $85.52 split-adjusted

What $1,000 or $10,000 in THRM Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Nov 20, 2015
$1,000 $896 -10% $355 -65% $974 -3% $623 -38%
$10,000 $8,958 -10% $3,548 -65% $9,740 -3% $6,230 -38%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-18. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for THRM

$1,000 Investment Over Time

THRM vs S&P 500

Year-by-Year Returns

THRM annual performance
Year Start Price End Price Annual Return Cumulative
2015Nov 20 to Dec 31 $48.70 $47.40 -2.7% -2.7%
2016 $47.40 $33.85 -28.6% -30.5%
2017 $33.85 $31.75 -6.2% -34.8%
2018 $31.75 $39.98 +25.9% -17.9%
2019 $39.98 $44.39 +11.0% -8.9%
2020 $44.39 $65.22 +46.9% +33.9%
2021 $65.22 $86.90 +33.2% +78.4%
2022 $86.90 $65.29 -24.9% +34.1%
2023 $65.29 $52.36 -19.8% +7.5%
2024 $52.36 $39.93 -23.7% -18.0%
2025 $39.93 $36.37 -8.9% -25.3%
2026Dec 31, 2025 to Nov 18 $36.37 $30.34 -16.6% -37.7%

About Gentherm Inc

Consumer Cyclical · NASDAQ

Gentherm Inc (NASDAQ: THRM) is an automotive and medical technology company focused on thermal management and pneumatic comfort solutions. According to company disclosures, Gentherm describes itself as a global market leader in these technologies, serving both the automotive and healthcare industries through specialized products that manage temperature and enhance comfort.

Gentherm operates through two primary business areas: Automotive and Medical. The Automotive segment, identified in prior descriptions as the main revenue contributor, includes climate comfort systems, cable systems, battery performance solutions, and automotive electronics and software systems. Company news releases further specify that automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), lumbar and massage comfort solutions, valve systems, heated interior systems such as heated seats, steering wheels, armrests and other components, as well as other electronic devices.

In the Medical segment, Gentherm focuses on patient temperature management systems. The company states that it offers a full patient temperature management portfolio and references products such as the Astopad® resistive warming system and a Vytil-branded convective warming system manufactured by Gentherm for distribution in European markets. These solutions are designed for use by healthcare providers and clinicians in hospital and medical practice settings, with an emphasis on quality and safety.

Gentherm’s disclosures indicate that it is a manufacturing-sector company classified in Motor Vehicle Gasoline Engine and Engine Parts Manufacturing. The firm’s automotive activities center on climate and comfort technologies integrated into vehicle interiors and related systems, while its medical activities relate to regulated patient temperature management devices. The company has highlighted its role in securing substantial automotive new business awards and in expanding distribution partnerships for its medical portfolio.

Gentherm’s stock trades on the NASDAQ under the ticker symbol THRM. Company news releases describe Gentherm as having facilities in multiple countries and more than 14,000 employees, reflecting a global operational footprint. The firm notes that it has facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Mexico, Morocco, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam, and also references geographical segments that include the United States, China, South Korea, Germany, Japan, the Czech Republic and other countries.

Across its disclosures, Gentherm emphasizes the development of new technologies and products intended to improve existing offerings and create new applications in both existing and new markets. In the automotive area, this includes continued work on climate control seats, interior comfort systems and related electronics. In the medical area, it includes expanding access to its patient temperature management portfolio through partnerships with distributors such as DUOMED in Europe.

Gentherm also reports on its financial and operational performance through regular earnings releases and associated SEC filings. These communications highlight product revenues from automotive and medical segments, automotive climate and comfort solutions, and the volume of automotive new business awards. The company discusses factors that influence its results, such as material and labor costs, supply chain conditions, foreign currency effects, and the production levels of major automotive customers in its relevant markets.

According to its own statements, Gentherm’s strategy includes scaling its core technologies across multiple end markets, optimizing its global manufacturing footprint, and pursuing operating efficiencies. Management commentary in earnings releases references efforts such as product lifecycle management, evaluation of new market opportunities, and standardization of key processes. The company also notes that it evaluates and uses various non-GAAP financial measures, including Adjusted EBITDA, free cash flow, net capital expenditures, Net Debt, liquidity and net leverage, to assess operating performance and liquidity.

Business Segments

Automotive

  • Automotive climate comfort systems, including Climate Control Seats (CCS®) and Climate Control Interiors (CCI™)
  • Lumbar and massage comfort solutions, including the pulsating massage solution Puls.A™ referenced in company news
  • Valve systems and other automotive electronics and software systems
  • Heated automotive interior systems such as heated seats, steering wheels, armrests and other components
  • Battery performance solutions and automotive cable systems

Medical

  • Patient temperature management systems used in the medical industry
  • Resistive and convective warming systems, including Astopad® and Vytil-branded convective warming systems manufactured by Gentherm for distribution in certain European markets

Geographic Scope

Gentherm identifies geographic segments that include the United States, China, South Korea, Germany, Japan, the Czech Republic and other countries. In addition, the company states that it has facilities in a broader set of countries across North America, Europe and Asia, reflecting a global manufacturing and operational base.

Risk and Regulatory Context

In its earnings releases and related forward-looking statements, Gentherm outlines a range of factors that can affect its business, including macroeconomic and geopolitical conditions in the automotive industry, trade policies and tariffs, competition, supply chain constraints, foreign currency and exchange risk, regulatory oversight of its medical business, and product quality and safety considerations. The company refers readers to its Annual Report on Form 10-K and subsequent SEC filings for detailed risk factor discussions.

Market Cap
$1.7B
Current Price
$30.34
EPS (FY2025)
$0.59
Revenue (FY2025)
$1.5B
Net Margin (FY2025)
1.2%
View full THRM overview

Frequently Asked Questions

Gentherm Inc investment returns

How much would $1,000 invested in Gentherm Inc be worth today?

If you invested $1,000 in Gentherm Inc (THRM) 10 years ago on 2016-11-21, your investment would be worth $974 as of 2026-11-18, a -2.6% price return without dividends, growing at a compounded rate of -0.3% per year (CAGR).

Has Gentherm Inc outperformed the S&P 500?

Over the past 10 years, THRM returned -2.6% compared to +231.7% for the S&P 500, underperforming the benchmark by 234.3 percentage points.

What is Gentherm Inc's average annual return?

The compound annual growth rate (CAGR) of THRM’s share price over the past 10 years is -0.3%, without dividends. Individual years vary a great deal, and THRM’s best recent full year was 2020 (+46.9%) while the worst was 2016 (-28.6%).

For informational and educational purposes only, not investment advice.